Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Abstract

Background Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. MethodsWe estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 23 pathogens and 88 pathogen-drug combinations in 204 countries and territories in 2019. We obtained data from systematic literature reviews, hospital systems, surveillance systems, and other sources, covering 471 million individual records or isolates and 7585 study-location-years. We used predictive statistical modelling to produce estimates of AMR burden for all locations, including for locations with no data. Our approach can be divided into five broad components: number of deaths where infection played a role, proportion of infectious deaths attributable to a given infectious syndrome, proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antibiotic of interest, and the excess risk of death or duration of an infection associated with this resistance. Using these components, we estimated disease burden based on two counterfactuals: deaths attributable to AMR (based on an alternative scenario in which all drugresistant infections were replaced by drug-susceptible infections), and deaths associated with AMR (based on an alternative scenario in which all drug-resistant infections were replaced by no infection). We generated 95% uncertainty intervals (UIs) for final estimates as the 25th and 975th ordered values across 1000 posterior draws, and models were cross-validated for out-of-sample predictive validity. We present final estimates aggregated to the global and regional level. FindingsOn the basis of our predictive statistical models, there were an estimated 4•95 million (3•62-6•57) deaths associated with bacterial AMR in 2019, including 1•27 million (95% UI 0•911-1•71) deaths attributable to bacterial AMR. At the regional level, we estimated the all-age death rate attributable to resistance to be highest in western sub-Saharan Africa, at 27•3 deaths per 100 000 (20•9-35•3), and lowest in Australasia, at 6•5 deaths (4•3-9•4) per 100 000. Lower respiratory infections accounted for more than 1•5 million deaths associated with resistance in 2019, making it the most burdensome infectious syndrome. The six leading pathogens for deaths associated with resistance (Escherichia coli, followed by Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) were responsible for 929 000 (660 000-1 270 000) deaths attributable to AMR and 3•57 million (2•62-4•78) deaths associated with AMR in 2019. One pathogen-drug combination, meticillinresistant S aureus, caused more than 100 000 deaths attributa...

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

“…The AMR deaths due to resistance were predicted to be the highest in sub-Saharan Africa and lowest in Australasia. Furthermore, it was predicted that methicillin-resistant Staphylococcus aureus (MRSA) was responsible for half a million deaths, while the six pathogens Escherichia coli , Staphylococcus aureus , Klebsiella pneumoniae , Streptococcus pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were attributed to between 50,000 and 100,000 deaths [ 5 ].…”

Multi-excitation Raman Spectroscopy Complements Whole Genome Sequencing for Rapid Detection of Bacterial Infection and Resistance in WHO Priority Pathogens

“…This, together with the increased and inappropriate use of existing antibiotics means that we are heading towards a world in which many antibiotics are no longer effective. In addition to becoming the third leading cause of death 1 , antimicrobial resistance (AMR) has an enormous impact on worldwide economy. Each year the USA is losing US $55 billion and EU/EEA €1.6 billion due to the AMR 2 .…”

“…These pathogens have acquired resistance towards many antibiotics, including last-resort antibiotics such as carbapenems and colistin and are thus associated with high morbidity and mortality rates 4 . In 2019, 1.27 million people died due to resistant bacteria infections and 73% of them were caused by E. coli, S. aureus, K. pneumoniae, S. pneumoniae, A. baumannii and P. aeruginosa 1 .…”

Phage Paride hijacks bacterial stress responses to kill dormant, antibiotic-tolerant cells

“…This trend has reversed in recent years when phages, owing to advances in medicine and biotechnology, have been increasingly used as attractive treatment options for multidrug-resistant bacterial infections 3,4,17-19 . Given the bleak prospects of the antibiotic resistance crisis with around five million deaths linked to resistant bacterial infections in 2019 5 , this trend is likely going to continue.…”